Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
المؤلفون الرئيسيون: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Oxford University Press
2018
|
مواد مشابهة
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
حسب: Wattanakul, T, وآخرون
منشور في: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
حسب: Thanaporn Wattanakul, وآخرون
منشور في: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
حسب: Chotsiri, P, وآخرون
منشور في: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
حسب: Pukrittayakamee, S, وآخرون
منشور في: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
حسب: Saito, M, وآخرون
منشور في: (2018)